The clinical management of COVID-19 in pregnant women, who are considered a
vulnerable population, remains uncertain even as the pandemic subsides. SARS-CoV-2 …

The impact of the COVID-19 infection, caused by Severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), during the pandemic has been considerably more severe in …

Rheumatic and musculoskeletal diseases often affect individuals of childbearing age. The
incidence and prevalence of rheumatic and musculoskeletal diseases is rising. More …

Drug repurposing is an important strategy in COVID-19 treatment, but many clinically
approved compounds have not been extensively studied in the context of embryogenesis …

Background Preterm birth preceded by spontaneous preterm labour often occurs in the
clinical setting of sterile intra-amniotic inflammation (SIAI), a condition that currently lacks …

By January of 2023, the COVID-19 pandemic had led to a reported total of 6,700,883 deaths
and 662,631,114 cases worldwide. To date, there have been no effective therapies or …

Background: COVID-19 was an infection that was capable of bringing the entire world to a
standstill position within a period of days to months. Despite the advancements in the …

Background Drug use in pregnancy and lactation is challenging. It becomes more
challenging in pregnant and lactating women with certain critical clinical conditions such as …

Introduction: The COVID-19 pandemic caused by SARS-CoV-2 has been the major health
concern in 2019 globally. Considering the severity and phase of the disease, various …

Introduction: Although safety data demonstrated the efficacy and effectiveness of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination for all individuals over …